Xinguo Li
4 Papers
Xinguo Li is an academic researcher. The author has contributed to research in topics: Vaccination & Medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial
Shengli Xia,Kai Duan,Yuntao Zhang,Xiaoqing Zeng,Dongyang Zhao,Huajun Zhang,Zhiqiang Xie,Xinguo Li,Cheng Peng,Wei Zhang,Yunkai Yang,Wei Chen,Xiaoxiao Gao,Wangyang You,Xuewei Wang,Zejun Wang,Zhen-Nan Shi,Yan-xia Wang,Xuqin Yang,Qingliang Li,Lili Huang,Qian Wang,Jian Xin Lu,Yongli Yang,Jing Guo,Wei Zhou,X. Q. Wan,Cong Wu,Wenhui Wang,Shihe Huang,Jianhui Du,Xu Nian,T. Deng,Zhiming Yuan,Shuo Shen,Wanshen Guo,Jia Liu,Xiaoming Yang +37 more
TL;DR: The data demonstrate that WIBP-CorV is safe and well tolerated at all tested doses in participants aged 3-17 years, and elicited robust humoral responses against SARS-CoV-2 lasted for at least 6 months after the third vaccination.
COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan
Hong Liang,Xu Nian,Jun-Zheng Wu,Yongmei Liu,Lu Feng,Jia Lu,Yan Peng,Zhijun Zhou,T. Deng,Jing Liu,Deming Ji,Ran Qiu,Lian-Ying Lin,Yan-Jun Zeng,Fei Xia,Yong Hu,Tao Li,Kai Duan,Xinguo Li,Zejun Wang,Yong Zhang,Hang Zhang,Chendi Zhu,Shang-Zi Wang,Xiao Wu,Xiang Wang,Yuwei Li,Shihe Huang,Min Mao,Huanhuan Guo,Yunkai Yang,Rui Jia,J. XuFang,Xue-Wei Wang,Shuyan Liang,Zhixin Qiu,Juan Zhang,Yaling Ding,Chunyan Li,Jin Zhang,Daoxing Fu,Yanlin He,D Zhou,Cesheng Li,Jiayou Zhang,D. B. Yu,Xiaoming Yang +46 more
TL;DR: In this paper , the inactivated COVID-19 vaccine can stimulate immunity in recovered patients to maintain high levels of anti-receptor-binding domain (RBD) and anti-nucleocapsid protein (NP) antibody titers within 9 months, and high neutralizing activity against the prototype, Delta and Omicron strains was observed.
Liposome and QS-21 Combined Adjuvant Induces theHumoral and Cellular Responses of Acellular Pertussis Vaccine in a Mice Model
Baifeng Yang,De-quan Zhu,Jiayou Zhang,Shihe Huang,Xu Nian,Xinghang Li,Xinguo Li,Kai Duan,Xiaoming Yang +8 more
TL;DR: In this article , a novel adjuvant candidate was developed by combining liposome and QS-21 adjuvants, which provided robust protection against B. pertussis infection.
The assessment on cross immunity with smallpox virus and antiviral drug sensitivity of the isolated mpox virus strain WIBP-MPXV-001 in China
Yan-Jun Zeng,Xiaoke K. Liu,Yuwei Li,Jia Lu,Demiao Dan,Shiyun Lv,Fei Xia,Hao Zhang,Rui Jia,Kai Duan,Zejun Wang,Xinguo Li,Xiaoming Yang +12 more
TL;DR: In this paper , the authors reported the isolation and identification of MPXV from the vesicle swabs of this patient, which were inoculated in Vero and Vero E6 cells.